| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.21 | 0.05 |